According to KYORIN Pharmaceutical's latest financial reports the company has $0.13 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.14 B | -35.38% |
2022-03-31 | $0.22 B | -19.42% |
2021-03-31 | $0.27 B | -8.23% |
2020-03-31 | $0.30 B | 4.04% |
2019-03-31 | $0.29 B | -30.37% |
2018-03-31 | $0.42 B | -3.31% |
2017-03-31 | $0.43 B | -5.45% |
2016-03-31 | $0.46 B | 13.81% |
2015-03-31 | $0.40 B | -15.08% |
2014-03-31 | $0.47 B | 35.86% |
2013-03-31 | $0.35 B | 0.18% |
2012-03-31 | $0.34 B | -10.49% |
2011-03-31 | $0.39 B | 43.06% |
2010-03-31 | $0.27 B | 71.94% |
2009-03-31 | $0.15 B | 23.39% |
2008-03-31 | $0.12 B | 9.39% |
2007-03-31 | $0.11 B | -5.74% |
2006-03-31 | $0.12 B | 13.66% |
2005-03-31 | $0.10 B |